Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production

Annals of Neurology

Volumn 70, Issue 4, 2011, Pages 583-590

  Won, Seok Joon ^a   Tang, Xian Nan ^a   Suh, Sang Won ^a,c   Yenari, Midori A ^a   Swanson, Raymond A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; TISSUE PLASMINOGEN ACTIVATOR; ACETOPHENONE DERIVATIVE; ANTIOXIDANT; FIBRINOLYTIC AGENT; SWEETENING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STROKE; TREATMENT OUTCOME;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; GLUCOSE; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; STROKE; SUPEROXIDES; SWEETENING AGENTS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84855362074     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22538     Document Type: Article

References (47)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999;30: 34-39. (Pubitemid 29029438)
3. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59:669-674.
4. Alvarez-Sabin J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003;34:1235-1241.
5. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial. Neurology 2001;57:1603-1610. (Pubitemid 33055477)
6. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005;172:1307-1312. (Pubitemid 40745072)
7. De Silva DA, Ebinger M, Christensen S, et al. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis 2010;29:14-21.
8. Simpson MA, Dewey HM, Churilov L, et al. Thrombolysis for acute stroke in Australia: Outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008). Med J Aust 2010; 193:439-443.
9. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: A review of the risk factors. Cerebrovasc Dis 2007;24:1-10. (Pubitemid 47026135)
10. Muranyi M, Li PA. Hyperglycemia increases superoxide production in the CA1 pyramidal neurons after global cerebral ischemia. Neurosci Lett 2006;393:119-121. (Pubitemid 41821091)
11. Suh SW, Shin BS, Ma H, et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 2008;64: 654-663.
12. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. J Cereb Blood Flow Metab 1981;1:297-311. (Pubitemid 12246553)
13. Paljarvi L, Rehncrona S, Soderfeldt B, et al. Brain lactic acidosis and ischemic cell damage: Quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol 1983;60:232-240. (Pubitemid 13025680)
14. Wautier JL, Schmidt AM. Protein glycation: A firm link to endothelial cell dysfunction. Circ Res 2004;95:233-238. (Pubitemid 39056283)
15. Gobbel GT, Chan TY, Chan PH. Nitric oxide-and superoxidemediated toxicity in cerebral endothelial cells. J Pharmacol Exp Ther 1997;282:1600-1607. (Pubitemid 27408346)
16. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: A vascular perspective. J Cereb Blood Flow Metab 2007;27:435-451.
17. Suh SW, Gum ET, Hamby AM, et al. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007;117:910-918. (Pubitemid 46556747)
18. Gupte SA, Levine RJ, Gupte RS, et al. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J Mol Cell Cardiol 2006;41:340-349. (Pubitemid 44080215)
19. Decoursey TE, Ligeti E. Regulation and termination of NADPH oxidase activity. Cell Mol Life Sci 2005;62:2173-2193. (Pubitemid 41500537)
20. Tang J, Liu J, Zhou C, et al. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 2005;94:1342-1350. (Pubitemid 41232589)
21. Kahles T, Luedike P, Endres M, et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 2007;38:3000-3006. (Pubitemid 350035696)
22. Johnston KC, Hall CE, Kissela BM, et al. Glucose Regulation in Acute Stroke Patients (GRASP) trial: A randomized pilot trial. Stroke 2009;40:3804-3809.
23. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406. (Pubitemid 46551852)
24. Bruno A, Liebeskind D, Hao Q, Raychev R; for the UCLA Stroke Investigators. Diabetes mellitus, acute hyperglycemia, and ischemic stroke. Curr Treat Options Neurol 2010;12:492-503.
25. Won SJ, Xie L, Kim SH, et al. Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res 2006;1123:237-244.
26. Tang XN, Cairns B, Cairns N, Yenari MA. Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 2008;154:556-562.
27. Tang XN, Berman AE, Swanson RA, Yenari MA. Digitally quantifying cerebral hemorrhage using Photoshop and Image J. J Neurosci Methods 2010;190:240-243.
28. Maier CM, Sun GH, Kunis D, et al. Delayed induction and longterm effects of mild hypothermia in a focal model of transient cerebral ischemia: Neurological outcome and infarct size. J Neurosurg 2001;94:90-96. (Pubitemid 32799477)
29. Chen W, Jadhav V, Tang J, Zhang JH. HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxic-ischemic injury. Acta Neurochir Suppl 2008;102:395-399.
30. Chan PH, Kawase M, Murakami K, et al. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci 1998;18:8292-8299. (Pubitemid 28465005)
31. Hayashi T, Saito A, Okuno S, et al. Damage to the endoplasmic reticulum and activation of apoptotic machinery by oxidative stress in ischemic neurons. J Cereb Blood Flow Metab 2005;25:41-53. (Pubitemid 40096896)
32. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 1994;11:95-102.
33. Yip PK, He YY, Hsu CY, et al. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 1991;41: 899-905.
34. Plum F. What causes infarction in ischemic brain? The Robert Wartenberg Lecture. Neurology 1983;33:222-223.
35. Jian Liu K, Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 2005;39: 71-80. (Pubitemid 40733117)
36. Wang X, Tsuji K, Lee SR, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 2004;35:2726-2730. (Pubitemid 39458380)
37. Omori K, Ohira T, Uchida Y, et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol 2008;84:292-301. (Pubitemid 351960304)
38. Brennan AM, Suh SW, Won SJ, et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 2009;12:857-863.
39. Bang OY, Saver JL, Alger JR, et al. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke 2009;40:454-461.
40. Ennis SR, Keep RF. Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab 2007;27:1573-1582. (Pubitemid 47301440)
41. Kamada H, Yu F, Nito C, Chan PH. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: Relation to blood-brain barrier dysfunction. Stroke 2007;38:1044-1049. (Pubitemid 46568472)
42. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001;32:2426-2432. (Pubitemid 32954818)
43. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan Stroke Study. Neurology 1994;44:626-634. (Pubitemid 24129987)
44. Zhang L, Zhang ZG, Zhang C, et al. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke 2004;35:2890-2895. (Pubitemid 39565190)
45. Korninger C, Collen D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 1981;46:561-565. (Pubitemid 11049531)
46. Dzialowski I, Pexman JH, Barber PA, et al. Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke 2007;38:75-79. (Pubitemid 46035609)
47. Kimura K, Iguchi Y, Shibazaki K, et al. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. J Neurol Sci 2008;272:136-142.